Novel peptide calcitonin gene-related peptide antagonists for migraine therapy.

Patrick M KilloranVicky CapelVera D'AloisioAdam SchofieldTímea AczélKata BölcskeiZsuzsanna HelyesBengt von MentzerDavid A KendallChris R CoxonGillian A Hutcheon

Published in: The Journal of pharmacy and pharmacology (2023)

The project has demonstrated the potential of these novel small peptide CGRP antagonists, to undergo future preclinical evaluation as anti-migraine therapeutics.

Keyphrases

quality improvement
small molecule
stem cells
cell therapy
gene expression
risk assessment
human health